Bidirectional association between pneumonia and intestinal infection: an analysis of the MIMIC-IV database
Weiqian Hou1,2, Yi Zhu1, Xigui Lai3
1The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China.
Abstract:
The purpose is to analyze the prevalence of intestinal infection in patients with pneumonia in intensive care units (ICU) and the impact of intestinal infection on the prognosis of patients with pneumonia, so as to explore the bidirectional association between pneumonia and intestinal infection. The study aims to investigate the correlation between the occurrence of pneumonia and intestinal infection among patients in the ICU, utilizing the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, as well as the impact of intestinal infection on the prognosis of pneumonia patients. The enrolled patients were first divided into pneumonia group and non-pneumonia group, and the primary outcome was that patients developed intestinal infection. Multivariate logistic regression was used to elucidate the association between pneumonia and the prevalence of intestinal infection, and propensity score matching (PSM) and inverse probability of treatment weighing (IPTW) were used to validate our findings. We then divided patients with pneumonia into two groups according to whether they were complicated by intestinal infection, and analyzed the effect of intestinal infection on 28-day mortality, length of ICU stay, and length of hospital stay in patients with pneumonia. This study included 50,920 patients, of which 7493 were diagnosed with pneumonia. Compared with non-pneumonia patients, the incidence of intestinal infection in pneumonia patients was significantly increased [OR 1.58 (95% CI 1.34-1.85; P < 0.001)]. Cox proportional hazards regression model showed no significant effect of co-infection on 28-day mortality in patients with pneumonia (P = 0.223). Patients in the intestinal infection group exhibited a longer length stay in ICU and hospital than those without intestinal infection (P < 0.001). In the ICU, patients with pneumonia were more likely linked to intestinal infection. In addition, the presence of concurrent intestinal infections can prolong both ICU and hospital stays for pneumonia patients.
Insights
Pneumonia patients in intensive care units (ICUs) have a higher risk of intestinal infection. While not impacting mortality, concurrent intestinal infections significantly prolong ICU and hospital stays for pneumonia patients.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Gastroenterology
Background:
- Pneumonia is a common critical illness in intensive care units (ICUs).
- Intestinal infections are potential complications in critically ill patients.
- The bidirectional relationship between pneumonia and intestinal infection requires further investigation.
Purpose of the Study:
- To analyze the prevalence of intestinal infection in ICU patients with pneumonia.
- To assess the impact of intestinal infection on the prognosis of pneumonia patients.
- To explore the association between pneumonia and intestinal infection in the ICU setting.
Main Methods:
- Utilized the Medical Information Mart for Intensive Care IV (MIMIC-IV) database.
- Employed multivariate logistic regression, propensity score matching (PSM), and inverse probability of treatment weighting (IPTW).
- Analyzed 28-day mortality, ICU length of stay, and hospital length of stay.
Main Results:
- Pneumonia patients exhibited a significantly increased incidence of intestinal infection (OR 1.58).
- Intestinal infection did not significantly affect 28-day mortality in pneumonia patients (P=0.223).
- Patients with concurrent intestinal infections had longer ICU and hospital stays (P<0.001).
Conclusions:
- Pneumonia is associated with a higher likelihood of developing intestinal infection in ICU patients.
- Concurrent intestinal infections prolong the length of stay for pneumonia patients in ICUs and hospitals.
- Further research may explore targeted interventions for intestinal infections in pneumonia patients.
More Related Videos
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Viral Recombination
